2023 SNO/ASCO CNS Cancer Conference Recordings

The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Click Register/Take Course to watch the recordings
This course is not for credit.
Please log in using the SNO account created during Registration.
The Access Code can be found in the Post Conference Email.

For technical assistance, please email academy@soc-neuro-onc.org .


2023 SNO/ASCO CNS Cancer Conference
August 10-12, 2023
Hyatt Regency Embarcadero - San Francisco, California


Overview

The 2023 SNO/ASCO CNS Cancer Conference — Accelerating therapeutic discovery and advancing care of patients with primary and metastatic CNS malignancies — will be held August 10-12, 2023, in San Francisco, California. The goal of this annual conference is to provide a deeper dive into the basic science of brain metastases and neuro-oncology clinical trials. Together, we will make significant improvements in survival and quality of life of patients with primary and metastatic cancers of the central nervous system. 

This collaborative conference will:

  • stimulate basic, translational, and clinical research in CNS metastases;

  • engage clinical researchers in innovative trial designs for primary and secondary CNS malignancies;

  • address the needs of patients with intracranial tumors.

These areas of great unmet need will be addressed in a dynamic and interactive framework. The structure brings together various disciplines to emphasize basic and translational research on brain metastases as well as clinical trial design and outcomes in primary and metastatic intracranial tumors. Research highlighting novel approaches, innovative ideas, and recent advances in neuro-oncology clinical trials will be presented and discussed. There will be a unique opportunity for collaboration and exchange of ideas between those dedicated to the science and care of patients with primary and secondary malignancies of the CNS.

Target Audience

Neuro-oncologists (both neurology and medical oncology-trained), Medical Oncologists, Neurosurgeons, Neuro-radiologists, Neuropathologists, Neuropsychologists, Radiation Oncologists, Basic and Translational Scientists, Basic and Clinical Science Trainees, Allied Health Professionals, Palliative Care Professionals, Industry Professionals, Regulatory and Government Officials, Patient Advocates and Nursing Professionals.

Learning Objectives

  1. Explain new CNS-penetrant systemic agents in the context of multidisciplinary care for the treatment of CNS metastases.
  2. Discuss new developments in local therapeutic approaches and diagnostics in the treatment of CNS metastases.
  3. Explain the role of the tumor microenvironment in CNS metastases.
  4. Compare clinical trials designs incorporating recent advances such as liquid biopsy, novel prognostic biomarkers, and advanced neuroimaging for the treatment of CNS malignancies.
  5. Outline challenges for the development and approval of novel therapies for CNS cancers.
Course summary
Course opens: 
12/01/2022
Course expires: 
06/23/2024
Cost:
$0.00

Planning Committee Leadership

Co-Chairs 
Adrienne Boire, Memorial Sloan Kettering Cancer Center 
Sarah Goldberg, Yale School of Medicine 

Co-Chairs Elect   
Priya Kumthekar, Northwestern Medicine 
Hussein Tawbi, University of Texas MD Anderson Cancer Center

Immediate Past Co-Chairs 
Priscilla Brastianos, Massachusetts General Hospital, Harvard Medical School 
Mustafa Khasraw, Duke University 
 
Planning Committee 
Stephen Bagley, University of Pennsylvania
Evanthia Galanis, Mayo Clinic Rochester
Vinai Gondi, Northwestern Medicine Cancer Center Warrenville and Proton Center  
Jona Hattangadi-Gluth, University of California, San Diego
Sara Hurvitz, University of California, Los Angeles
Emilie Le Rhun, University Hospital Zurich, Switzerland
Nancy Lin, Dana Farber Cancer Institute
Minesh Mehta, Miami Cancer Institute
Josh Neman, University of Southern California, Los Angeles
Michael Platten, University Medical Center Mannheim
Solmaz Sahebjam, National Cancer Institute, National Institutes of Health
Debra Nana Yeboa, University of Texas MD Anderson Cancer Center

The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Price

Cost:
$0.00
Please login or register to take this course.

Please fill out the webform at the time of enrollment. *See step 2 in the instructions.

Instructions on How to Watch the Module:

  1. Click the Take Course Button
  2. On the course progress bar, click the webform.
  3. Click the blue start button to fill out the webform.
  4. Complete the webform, then click submit.
  5. Then Click next to proceed to the video

If you have any technical difficulties or have any questions, please reach out to academy@soc-neuro-onc.org.